Remove medical-conditions parkinsons-disease
article thumbnail

Marijuana-Based Parkinson’s Medication Moves Forward

CannaMD

Parkinson’s disease is a type of neurodegeneration characterized by tremors, issues with balance, and other movement-related problems. Patients with Parkinson’s disease also frequently suffer from mood issues such as apathy and depression. Parkinson’s Disease: Marijuana Studies. What is GB Sciences?

article thumbnail

1 in 5 Parkinson’s Patients Use Cannabis

CannaMD

A new study indicates that a significant number of persons suffering from Parkinson’s disease use medical marijuana for symptom relief. Parkinson’s Disease & Marijuana Study. Survey participants had an average age of 71 and a disease duration of just over 7 years.

Patients 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Iowa Bill Seeking ‘Vaporizable’ Cannabis To Be On State-Approved List

Veriheal

In January, a bill was introduced regarding Iowas medical cannabis program, allowing vaporized cannabis to be added to the state-approved Tetrahydrocannabinol ( THC) products list. If passed, vaporizable dried raw cannabis would be included with the products available to Iowas medical patients.

article thumbnail

Medical Marijuana Advances in North Carolina with Strong Senate Support

CannaMD

The North Carolina Senate has passed a bill legalizing medical marijuana under tight restrictions.

article thumbnail

Why more Parkinson’s patients don’t use cannabis

The Cannigma

The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness. What would be a decisive factor if they were to try medical cannabis?: An overwhelming 84.7% Altogether, 24.5% Shutterstock).

Patients 145
article thumbnail

IDPH approves four new conditions for medical cannabis treatment

Illinois News Joint

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.

article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. So what gives?

DEA 98